AtriCure
ATRC
224 hedge funds and large institutions have $1.51B invested in AtriCure in 2024 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 83 increasing their positions, 82 reducing their positions, and 40 closing their positions.
3.75% more ownership
Funds ownership: 100.6% → 104.35% (+3.8%)
1% more repeat investments, than reductions
Existing positions increased: 83 | Existing positions reduced: 82
4% less funds holding
Funds holding: 233 → 224 (-9)
11% less capital invested
Capital invested by funds: $1.7B → $1.51B (-$193M)
18% less first-time investments, than exits
New positions opened: 33 | Existing positions closed: 40
35% less call options, than puts
Call options by funds: $2.93M | Put options by funds: $4.48M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$80.4M |
| 2 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$19.3M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$17.6M |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
+$11.8M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$10.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$37.5M |
| 2 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
-$30M |
| 3 |
FAM
Fred Alger Management
New York
|
-$19.9M |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$14M |
| 5 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$12.4M |
ATRC Hedge Fund Activity: Q1 2024 in Review
224 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in AtriCure (ATRC) for Q1 2024, worth a combined $1.51B — down 11% from $1.7B a quarter earlier.
Sellers outnumbered buyers: 40 funds closed out of ATRC and 33 opened new positions — a net loss of 7 holders — while 82 trimmed existing stakes and 83 added.
The largest buyer was Fidelity Investments, adding an estimated $80.4M. The largest seller was Invesco, cutting an estimated $37.5M.
- 224 institutional investors held AtriCure (ATRC) as of Q1 2024, down from 233 in Q4 2023.
- Funds reported $1.51B of AtriCure stock for Q1 2024, down 11% quarter-over-quarter.
- 33 funds opened new AtriCure positions in Q1 2024 and 40 closed out, a net change of -7 holders.
- The largest AtriCure buyer in Q1 2024 was Fidelity Investments, an estimated $80.4M added.
- The largest AtriCure seller in Q1 2024 was Invesco, an estimated $37.5M sold.
Based on aggregated 13F filings for Q1 2024.